Demo Sign up Log In

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

R&D Expenses

$250.00M

Quarterly · Period ending: Jun 30, 2026 · USD

TEVA R&D Expenses

Latest reported$250.00Mperiod endingJun 30, 2026

Latest reported$250.00Mperiod endingJun 30, 2026

TEVA Quarterly R&D Expenses ($0.00 → $250.00M)

Quarterly R&D Expenses

High-resolution chart · PNG

TEVA r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	27,118,000
Mar 31, 2001	27,998,000
Dec 31, 2000	30,720,000
Sep 30, 2000	27,640,000
Jun 30, 2000	26,292,000
Mar 31, 2000	19,923,000
Dec 31, 1999	21,842,000
Sep 30, 1999	19,600,000
Jun 30, 1999	21,300,000
Mar 31, 1999	19,200,000
Dec 31, 1998	15,900,000
Sep 30, 1998	20,300,000
Jun 30, 1998	16,200,000
Mar 31, 1998	15,700,000
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Sep 30, 1987	0
Jun 30, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0
Mar 31, 1986	0
Dec 31, 1985	0
Sep 30, 1985	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.